婴儿性综合征的治疗实践:主要儿科中心的共识和差异
Christina Briscoe1, Akshat Katyayan2, Chellamani Harini1
1Department of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Pediatric neurology
|October 31, 2025
概括
婴儿发作综合征 (IESS) 的治疗方案显示出差异,尽管对初始疗法达成共识. 需要进行研究,以标准化治疗,以便在儿科中获得更好的结果.
科学领域:
- 儿科神经学 儿科神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床研究 临床研究
背景情况:
- 婴儿发作综合征 (IESS) 是一种严重的发育和脑病,需要及时治疗.
- 已建立的第一线疗法包括上腺皮质增生激素,普雷迪尼索隆和维格巴特林.
- 在医疗中心实施这些IESS治疗方案的假设变化.
研究的目的:
- 调查和比较美国不同中心对婴儿发作综合征 (IESS) 的治疗途径.
- 为了确定IESS的既定和替代疗法应用的变化.
- 了解诸如保险障碍等因素对治疗方案的影响.
主要方法:
- 一项REDCap调查由儿科研究联盟分发给75个美国中心.
- 提取和比较了治疗途径的特征.
- 在数据收集之前,标准治疗方案已被预定义.
主要成果:
- 三十六个中心参与,其中89%的IESS治疗途径经常受到保险障碍 (72%) 的影响.
- 大多数协议 (88%) 建议新发性IESS的标准疗程,其中63%倾向于顺序激素疗法/维加巴林和17%的组合疗法.
- 减轻副作用的方法有所不同,常见的是胃肠道预防和血压控制;还注意到性饮食和手术.
结论:
- 在IESS的第一线和第二线治疗方面存在广泛的共识,但在顺序与组合疗法,第三线治疗和不良事件监测方面观察到显著的变化.
- 这些发现凸显了进一步研究的必要性,以解决有关治疗策略的关键问题.
- 最终的目标是为IESS开发一个标准化的,基于共识的治疗方案,以优化患者的治疗结果.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
804
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
804
Antiepileptic Drugs: Glutamate Antagonists
880
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
880
Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Electroconvulsive Therapy
841
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
841


